675 related articles for article (PubMed ID: 17522398)
1. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.
Chan AT; Ogino S; Fuchs CS
N Engl J Med; 2007 May; 356(21):2131-42. PubMed ID: 17522398
[TBL] [Abstract][Full Text] [Related]
2. Aspirin use and survival after diagnosis of colorectal cancer.
Chan AT; Ogino S; Fuchs CS
JAMA; 2009 Aug; 302(6):649-58. PubMed ID: 19671906
[TBL] [Abstract][Full Text] [Related]
3. Aspirin use and risk of colorectal cancer according to BRAF mutation status.
Nishihara R; Lochhead P; Kuchiba A; Jung S; Yamauchi M; Liao X; Imamura Y; Qian ZR; Morikawa T; Wang M; Spiegelman D; Cho E; Giovannucci E; Fuchs CS; Chan AT; Ogino S
JAMA; 2013 Jun; 309(24):2563-71. PubMed ID: 23800934
[TBL] [Abstract][Full Text] [Related]
4. Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.
Cao Y; Nishihara R; Qian ZR; Song M; Mima K; Inamura K; Nowak JA; Drew DA; Lochhead P; Nosho K; Morikawa T; Zhang X; Wu K; Wang M; Garrett WS; Giovannucci EL; Fuchs CS; Chan AT; Ogino S
Gastroenterology; 2016 Nov; 151(5):879-892.e4. PubMed ID: 27475305
[TBL] [Abstract][Full Text] [Related]
5. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.
Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS
JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381
[TBL] [Abstract][Full Text] [Related]
6. Aspirin and colon cancer--targeting prevention?
Markowitz SD
N Engl J Med; 2007 May; 356(21):2195-8. PubMed ID: 17522404
[No Abstract] [Full Text] [Related]
7. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.
Ruder EH; Laiyemo AO; Graubard BI; Hollenbeck AR; Schatzkin A; Cross AJ
Am J Gastroenterol; 2011 Jul; 106(7):1340-50. PubMed ID: 21407185
[TBL] [Abstract][Full Text] [Related]
8. Updates on the molecular mechanisms of aspirin in the prevention of colorectal cancer: Review.
Belayneh YM; Amare GG; Meharie BG
J Oncol Pharm Pract; 2021 Jun; 27(4):954-961. PubMed ID: 33427041
[TBL] [Abstract][Full Text] [Related]
9. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
[TBL] [Abstract][Full Text] [Related]
10. Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer.
Cao Y; Nishihara R; Wu K; Wang M; Ogino S; Willett WC; Spiegelman D; Fuchs CS; Giovannucci EL; Chan AT
JAMA Oncol; 2016 Jun; 2(6):762-9. PubMed ID: 26940135
[TBL] [Abstract][Full Text] [Related]
11. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
Flossmann E; Rothwell PM;
Lancet; 2007 May; 369(9573):1603-13. PubMed ID: 17499602
[TBL] [Abstract][Full Text] [Related]
12. The association between low-dose aspirin use and the incidence of colorectal cancer: a nationwide cohort study.
Huang WK; Chiou MJ; Yu KH; Lin YC; Yang TS; Chen JS; Kuo CF; See LC
Aliment Pharmacol Ther; 2013 Aug; 38(4):432-9. PubMed ID: 23799975
[TBL] [Abstract][Full Text] [Related]
13. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
[No Abstract] [Full Text] [Related]
14. Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study.
García Rodríguez LA; Huerta-Alvarez C
Epidemiology; 2000 Jul; 11(4):376-81. PubMed ID: 10874542
[TBL] [Abstract][Full Text] [Related]
15. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
Bardia A; Ebbert JO; Vierkant RA; Limburg PJ; Anderson K; Wang AH; Olson JE; Vachon CM; Cerhan JR
J Natl Cancer Inst; 2007 Jun; 99(11):881-9. PubMed ID: 17551148
[TBL] [Abstract][Full Text] [Related]
16. Aspirin dose and duration of use and risk of colorectal cancer in men.
Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Wu K; Fuchs CS
Gastroenterology; 2008 Jan; 134(1):21-8. PubMed ID: 18005960
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention.
Benamouzig R; Uzzan B; Martin A; Deyra J; Little J; Girard B; Chaussade S;
Gut; 2010 May; 59(5):622-9. PubMed ID: 20427397
[TBL] [Abstract][Full Text] [Related]
18. Aspirin and the prevention of colorectal cancer.
Berman KS
N Engl J Med; 2003 Jun; 348(24):2466-7; author reply 2466-7. PubMed ID: 12803217
[No Abstract] [Full Text] [Related]
19. Colorectal cancer and nonsteroidal anti-inflammatory drugs.
Smalley WE; DuBois RN
Adv Pharmacol; 1997; 39():1-20. PubMed ID: 9160111
[TBL] [Abstract][Full Text] [Related]
20. Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer.
Benamouzig R; Uzzan B; Little J; Chaussade S
Curr Top Med Chem; 2005; 5(5):493-503. PubMed ID: 15974944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
